It says PBM or whatever we want to call it. It's, it can't be that. It has to be real transparency. It has to be an open system where people can see the real costs and take advantage of them. This is why President Trump has been pushing so hard on most favored nation status. And I agree with him because with where we are in the world today, why are we subsidizing the pharmaceutical cost for every other country in the world? (49:46–49:56)
CLAIM
Asserts the need for transparency in the PBM industry.
This is an excerpt from a raw transcript. The assertions have not been audited or verified. Tap the video to view the source footage and understand the context.